{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:19:19Z","timestamp":1769206759376,"version":"3.49.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ijid.2022.08.026","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T04:35:13Z","timestamp":1662438913000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?"],"prefix":"10.1016","volume":"124","author":[{"given":"Yiran E.","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russel J.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-0783","authenticated-orcid":false,"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2022.08.026_bib0001","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc2104974","article-title":"National Study Group for COVID-19 Vaccination. Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants","volume":"385","author":"Abu-Raddad","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0002","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.radcr.2021.05.033","article-title":"Myocarditis following COVID-19 vaccination","volume":"16","author":"Albert","year":"2021","journal-title":"Radiol Case Rep"},{"key":"10.1016\/j.ijid.2022.08.026_bib0003","series-title":"Coronavirus (COVID-19) vaccine-induced immune thrombotic thrombocytopenia (VITT)","author":"Aleem","year":"2022"},{"key":"10.1016\/j.ijid.2022.08.026_bib0004","article-title":"COVID-19-induced takotsubo cardiomyopathy: venturing beyond the obvious","volume":"65","author":"Almas","year":"2021","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.ijid.2022.08.026_bib0005","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2021.04.019","article-title":"SARS-CoV-2 vaccines: lights and shadows","volume":"88","author":"Angeli","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0007","unstructured":"AstraZeneca. COVID-19 vaccine AstraZeneca analysis print. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/972833\/COVID-19_AstraZeneca_Vaccine_Analysis_Print.pdf, 2021 (accessed 29 August 2021)."},{"key":"10.1016\/j.ijid.2022.08.026_bib0008","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1002\/1873-3468.13696","article-title":"Innate immunity to adenovirus: lessons from mice","volume":"593","author":"Atasheva","year":"2019","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ijid.2022.08.026_bib0009","first-page":"hcab252","article-title":"Acute myocardial infarction and myocarditis following COVID-19 vaccination [published online ahead of print, 2021 Sep 29]","author":"Aye","year":"2021","journal-title":"QJM"},{"key":"10.1016\/j.ijid.2022.08.026_bib0010","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1473-3099(22)00154-2","article-title":"Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study","volume":"22","author":"Bager","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2022.08.026_bib0011","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000990","article-title":"Non-steroidal anti-inflammatory drug use in acute myopericarditis: 12-month clinical follow-up","volume":"6","author":"Berg","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.ijid.2022.08.026_bib0013","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cpcardiol.2012.07.003","article-title":"Sex and gender differences in myocarditis and dilated cardiomyopathy","volume":"38","author":"Fairweather","year":"2013","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0014","first-page":"e13651","article-title":"Untimely myocardial infarction or COVID-19 vaccine side effect","volume":"13","author":"Boivin","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.ijid.2022.08.026_bib0015","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1016\/j.jacc.2020.04.028","article-title":"Clinical implications of SARS-CoV-2 interaction with renin angiotensin system: JACC review topic of the week","volume":"75","author":"Brojakowska","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0016","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2459\/JCM.0000000000001232","article-title":"Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines","volume":"23","author":"Calcaterra","year":"2022","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.ijid.2022.08.026_bib0017","series-title":"Features, evaluation, and treatment of coronavirus (COVID-19)","author":"Cascella","year":"2022"},{"key":"10.1016\/j.ijid.2022.08.026_bib0018","unstructured":"Centers for Disease Control and Prevention (U.S.). The Vaccine Adverse Event Reporting System (VAERS) 2022. https:\/\/wonder.cdc.gov\/, (accessed 4 August 2022)."},{"key":"10.1016\/j.ijid.2022.08.026_bib0019","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41591-021-01446-y","article-title":"mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar","volume":"27","author":"Chemaitelly","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0020","first-page":"355","article-title":"Addressing vaccine-induced immune thrombotic thrombocytopenia (VITT) following COVID-19 vaccination: a mini-review of practical strategies","volume":"37","author":"Chen","year":"2021","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.ijid.2022.08.026_bib0021","doi-asserted-by":"crossref","first-page":"12522","DOI":"10.1021\/acsnano.0c07197","article-title":"COVID-19 vaccine frontrunners and their nanotechnology design","volume":"14","author":"Chung","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijid.2022.08.026_bib0022","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-246580","article-title":"Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination","volume":"14","author":"Crane","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ijid.2022.08.026_bib0024","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13136","article-title":"Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 randomized clinical trial","volume":"3","author":"Deftereos","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijid.2022.08.026_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101482","article-title":"Sex differences in inflammation, redox biology, mitochondria and autoimmunity","volume":"31","author":"Di Florio","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0026","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jama.2021.13443","article-title":"Myocarditis and pericarditis after vaccination for COVID-19","volume":"326","author":"Diaz","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2022.08.026_bib0027","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic","volume":"75","author":"Driggin","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0028","doi-asserted-by":"crossref","first-page":"101895","DOI":"10.1016\/j.legalmed.2021.101895","article-title":"Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty\u00ae)","volume":"51","author":"Edler","year":"2021","journal-title":"Leg Med (Tokyo)"},{"key":"10.1016\/j.ijid.2022.08.026_bib0029","doi-asserted-by":"crossref","first-page":"e2318","DOI":"10.1002\/rmv.2318","article-title":"Cardiac complications following mRNA COVID-19 vaccines: a systematic review of case reports and case series","volume":"32","author":"Fazlollahi","year":"2022","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0030","unstructured":"FDA briefing: Document: Pfizer-BioNTech. COVID-19 vaccine. Vaccines and related biological products advisory committee meeting. https:\/\/www.fda.gov\/media\/144245\/download, 2021 (accessed 16 July 2021)."},{"key":"10.1016\/j.ijid.2022.08.026_bib0031","first-page":"223","article-title":"Takotsubo syndrome after receiving the COVID-19 vaccine","volume":"24","author":"Fearon","year":"2021","journal-title":"J Cardiol Cases"},{"key":"10.1016\/j.ijid.2022.08.026_bib0032","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","article-title":"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review","volume":"28","author":"Fiolet","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2022.08.026_bib0033","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jacc.2018.06.016","article-title":"Long-term prognosis of patients with takotsubo syndrome","volume":"72","author":"Ghadri","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0034","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/eurheartj\/ehy076","article-title":"International expert consensus document on takotsubo syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology","volume":"39","author":"Ghadri","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijid.2022.08.026_bib0035","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0036","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211040110","article-title":"Concern about the adverse effects of thrombocytopenia and thrombosis after adenovirus-vectored COVID-19 vaccination","volume":"27","author":"Haimei","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ijid.2022.08.026_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2021.101077","article-title":"Clinical cardiovascular adverse events reported post-COVID-19 vaccination: are they a real risk?","volume":"47","author":"Hana","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0038","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2022.08.026_bib0039","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(21)00528-6","article-title":"Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster","volume":"397","author":"Hung","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2022.08.026_bib0040","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1080\/09537104.2020.1828574","article-title":"Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty","volume":"32","author":"Hwang","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.ijid.2022.08.026_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26165004","article-title":"An update on COVID-19 vaccine induced thrombotic thrombocytopenia syndrome and some management recommendations","volume":"26","author":"Islam","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijid.2022.08.026_bib0042","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.2147\/IJGM.S324349","article-title":"Cardiovascular adverse events reported from COVID-19 vaccines: a study based on WHO database","volume":"14","author":"Jeet Kaur","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0043","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1080\/21645515.2021.1995283","article-title":"Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?","volume":"17","author":"Joshi","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijid.2022.08.026_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100102","article-title":"Major cardiac concerns in therapy and vaccinations for COVID-19","volume":"11","author":"Junapudi","year":"2021","journal-title":"Metabol Open"},{"key":"10.1016\/j.ijid.2022.08.026_bib0045","first-page":"e32","article-title":"Corticosteroid therapy in management of myocarditis associated with COVID-19; a systematic review of current evidence","volume":"9","author":"Kamarullah","year":"2021","journal-title":"Arch Acad Emerg Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0046","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12291-021-00968-z","article-title":"Adverse events reported from COVID-19 vaccine trials: a systematic review","volume":"36","author":"Kaur","year":"2021","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.ijid.2022.08.026_bib0047","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/jamacardio.2021.2828","article-title":"Patients with acute myocarditis following mRNA COVID-19 vaccination","volume":"6","author":"Kim","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0048","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2005.08.007","article-title":"Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm?","volume":"110","author":"Kounis","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0049","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.amjcard.2021.09.032","article-title":"Acute myocardial infarction within 24 hours after COVID-19 vaccination: is Kounis syndrome the culprit?","volume":"162","author":"Kounis","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0050","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/CIRCULATIONAHA.114.010376","article-title":"Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis","volume":"130","author":"Kyt\u00f6","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijid.2022.08.026_bib0051","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000755","article-title":"Autoimmune basis for postural tachycardia syndrome","volume":"3","author":"Li","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ijid.2022.08.026_bib0052","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.2147\/IDR.S323280","article-title":"A postoperative man with Marfan syndrome with palpitations and chest pain after receiving the SARS-CoV-2 vaccine","volume":"14","author":"Li","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijid.2022.08.026_bib0053","doi-asserted-by":"crossref","first-page":"n1435","DOI":"10.1136\/bmj.n1435","article-title":"Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study","volume":"373","author":"Li","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2022.08.026_bib0054","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3390\/vaccines10020308","article-title":"Death after the administration of COVID-19 vaccines approved by EMA: has a causal relationship been demonstrated?","volume":"10","author":"Maiese","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2022.08.026_bib0055","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s11739-021-02793-x","article-title":"Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines","volume":"16","author":"Marcucci","year":"2021","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0056","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","article-title":"A global database of COVID-19 vaccinations","volume":"5","author":"Mathieu","year":"2021","journal-title":"Nat Hum Behav"},{"key":"10.1016\/j.ijid.2022.08.026_bib0057","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel","volume":"385","author":"Mevorach","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0058","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/CIRCEP.111.965343","article-title":"Altered systemic hemodynamic and baroreflex response to angiotensin II in postural tachycardia syndrome","volume":"5","author":"Mustafa","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0059","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cbdd.13898","article-title":"SARS-CoV-2 first contact: spike-ACE2 interactions in COVID-19","volume":"98","author":"Nesci","year":"2021","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.ijid.2022.08.026_bib0060","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2022.08.026_bib0061","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jemermed.2021.04.018","article-title":"Type 1 Kounis syndrome induced by inactivated SARS-COV-2 vaccine","volume":"61","author":"\u00d6zdemir","year":"2021","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0062","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1186\/s13063-020-04775-4","volume":"21","author":"Palacios","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.ijid.2022.08.026_bib0063","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1536\/ihj.21-550","article-title":"Acute coronary syndrome after inactivated SARS-COV-2 vaccine","volume":"63","author":"Panthong","year":"2022","journal-title":"Int Heart J"},{"key":"10.1016\/j.ijid.2022.08.026_bib0064","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.3390\/v13122493","article-title":"Cardiomyopathy associated with anti-SARS-CoV-2 vaccination: what do we know?","volume":"13","author":"Parra-Lucares","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2022.08.026_bib0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jamainternmed.2021.7382","article-title":"Odds of testing positive for SARS-CoV-2 following receipt of 3 vs 2 doses of the BNT162b2 mRNA vaccine","volume":"182","author":"Patalon","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0066","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0067","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41591-021-01548-7","article-title":"Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK","volume":"27","author":"Pouwels","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0068","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1002\/jmv.27810","article-title":"Vaccines for COVID-19: an insight on their effectiveness and adverse effects","volume":"94","author":"Qamar","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0069","first-page":"e14837","article-title":"A case of postural orthostatic tachycardia syndrome secondary to the messenger RNA COVID-19 vaccine","volume":"13","author":"Reddy","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.ijid.2022.08.026_bib0070","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1073\/pnas.112202999","article-title":"Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets","volume":"99","author":"Rocca","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2022.08.026_bib0071","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5152\/AnatolJCardiol.2021.1212","article-title":"Kounis syndrome associated with BNT162b2 mRNA COVID-19 vaccine presenting as ST-elevation acute myocardial infarction","volume":"26","author":"\u015eanc\u0131","year":"2022","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0072","first-page":"e6556","article-title":"Management of takotsubo syndrome: a comprehensive review","volume":"12","author":"Sattar","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ijid.2022.08.026_bib0073","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0074","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0075","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ijid.2022.08.026_bib0076","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.jcmg.2021.06.002","article-title":"Possible association between COVID-19 vaccine and myocarditis: clinical and CMR findings","volume":"14","author":"Shaw","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ijid.2022.08.026_bib0077","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1473-3099(22)00141-4","article-title":"EAVE II Collaborators. Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design","volume":"22","author":"Sheikh","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2022.08.026_bib0078","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(21)01358-1","article-title":"Public Health Scotland and the EAVE II Collaborators. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness","volume":"397","author":"Sheikh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2022.08.026_bib0079","first-page":"233","article-title":"A narrative review of COVID-19: the new pandemic disease","volume":"45","author":"Shirani","year":"2020","journal-title":"Iran J Med Sci"},{"key":"10.1016\/j.ijid.2022.08.026_bib0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40119-021-00248-0","article-title":"Cardiovascular complications of SARS-CoV-2 vaccines: an overview","volume":"11","author":"Shiravi","year":"2021","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.ijid.2022.08.026_bib0081","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1024\/0300-9831\/a000676","article-title":"Vitamin D can be effective on the prevention of COVID-19 complications: a narrative review on molecular aspects","volume":"92","author":"Shiravi","year":"2022","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.ijid.2022.08.026_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2013.06.039","article-title":"Takotsubo cardiomyopathy after anti-influenza vaccination: catecholaminergic effects of immune system","volume":"31","author":"Singh","year":"2013","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0083","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2021.02.035","article-title":"Recent randomized trials of antithrombotic therapy for patients with COVID-19: JACC state-of-the-art review","volume":"77","author":"Talasaz","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0084","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/s41591-021-01583-4","article-title":"BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar","volume":"27","author":"Tang","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0085","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa1406761","article-title":"Clinical features and outcomes of takotsubo (stress) cardiomyopathy","volume":"373","author":"Templin","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0086","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100101","article-title":"Vaccine induced thrombotic thrombocytopenia: the shady chapter of a success story","volume":"11","author":"Tsilingiris","year":"2021","journal-title":"Metabol Open"},{"key":"10.1016\/j.ijid.2022.08.026_bib0088","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/HYPERTENSIONAHA.120.15353","article-title":"COVID-19: ACE2 centric infective disease?","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ijid.2022.08.026_bib0089","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0090","first-page":"e15576","article-title":"Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines","volume":"13","author":"Vidula","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.ijid.2022.08.026_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ijid.2022.08.026_bib0092","doi-asserted-by":"crossref","first-page":"n699","DOI":"10.1136\/bmj.n699","article-title":"COVID-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots","volume":"372","author":"Wise","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2022.08.026_bib0093","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMoa2110737","article-title":"Myocarditis after COVID-19 vaccination in a large health care organization","volume":"385","author":"Witberg","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.08.026_bib0094","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejim.2021.06.013","article-title":"Blood pressure increase after Pfizer\/BioNTech SARS-CoV-2 vaccine","volume":"90","author":"Zappa","year":"2021","journal-title":"Eur J Intern Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222004982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222004982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:08:59Z","timestamp":1761120539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222004982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":94,"alternative-id":["S1201971222004982"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.08.026","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}